The Pharmacogenetics Roll Out – Gauging Response to Service [PROGRESS] programme is an NHS England funded transformation project led by researchers at Manchester University NHS Foundation Trust.
Read more
Greater Manchester residents are being encouraged to take part in a research study at MREH that aims to improve the diagnosis and treatment of conditions associated with sight loss.
Read more
A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with a commonly used antibiotic, is being trialled across 14 NHS neonatal units.
Read more
Researchers have shown that their system, developed at MFT, can identify more breast cancer patients who are eligible for testing for inherited faulty genes that can cause breast cancer.
Read more
To celebrate this year’s #Red4Research Day on Friday 20 September, Research Midwife, Emma Clark shares her career journey and her hopes to inspire others to get involved in research.
Read more
An innovative bedside genetic test developed by MFT researchers could dramatically improve outcomes for thousands of people in the UK affected by stroke each year.
Read more
Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from MFT has revealed.
Read more
Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies.
Read more
